NEJM Interview: Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market.
Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. J. Avorn. The $2.6 Billion Pill - Methodologic and Policy Considerations. N Engl J Med 2015;372:1877-9.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.